FDA’s GMP Recall Cost Savings Estimates Too High, CRN Says

Savings from avoiding illnesses caused by recalled dietary supplement products would be significantly less than FDA projects for its proposed supplement good manufacturing practices rule, the Council for Responsible Nutrition estimates